伊瓦布拉丁用于新生儿先天性宫外心力衰竭
1Pediatric Cardiology, Kahramanmaras Necip Fazıl Şehir Hastanesi, Kahramanmaras, Turkey.
Cardiology in the young
|December 18, 2023
概括
新生儿的先天性结节性宫外性心力衰竭 (CJET) 很少见,通常对标准治疗有抗性. 艾瓦布拉丁和阿米奥达龙的组合有效地管理了新生儿的CJET,提供了一个新的治疗选择.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 新生儿心律失常症 新生儿心律失常症
- 电子生理学 电子生理学
背景情况:
- 先天性结节异位性心力衰竭 (CJET) 是一种罕见的心律失常,在没有先前心脏手术的新生儿中发生.
- CJET可能对传统的抗不律性药物具有耐火性,这构成了重大的临床挑战.
研究的目的:
- 介绍一个6小时的新生儿被诊断出患有先天性结节性宫外心力衰竭的病例.
- 以突出成功管理耐药CJET使用新型组合疗法.
主要方法:
- 这位患者是一名6小时的新生儿,最初出现过渡性心跳动和脑上心跳动.
- 最初的治疗方法包括腺素,埃斯莫洛尔,心脏转变和静脉注射阿米奥达龙是无效的.
- 该疗法被升级为包括propranolol,其次是添加 ivabradine 由于持续的结节异位性心力衰竭.
主要成果:
- 伊瓦布拉丁和阿米奥达龙的结合导致心率显著降低到110/分钟.
- 停止使用普罗普兰诺洛尔,并将静脉注射的阿米奥达龙转换为口服.
- 患者的心律在开始服用伊瓦布拉丁和口服阿米奥达龙后的两天内转换为鼻腔节律.
结论:
- 出于心房节节或心房结节的结节性宫外性心力衰竭 (Junctional ectopic tachycardia) 通常对标准治疗有抗性.
- 伊瓦布拉丁是一种新型抗心律失常药物,显示出其作为耐火性先天性结节性宫外动心的治疗选择的潜力.
- 艾瓦布拉丁和阿米奥达龙的组合证明在治疗具有耐药CJET的新生儿方面是有效的.
更多相关视频
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
14.8K
05:12Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
3.2K
相关概念视频
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
844
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
844
01:28Disturbances in Heart Rhythm
970
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
970
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K